Infection Control Market Size(US$)

CAGR 2025-2031
3.7%
Market Size,2031
USD 24,020
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Infection Control was estimated to be worth US$ 18690 million in 2024 and is forecast to a readjusted size of US$ 24020 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
North American market for Infection Control was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Infection Control was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Infection Control was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Infection Control include STERIS, Getinge, Ecolab, 3M, Advanced Sterilization Products, Cantel Medical, Sotera Health, MMM Group, Matachana, Belimed AG, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Infection Control, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Infection Control by region & country, by Type, and by Application.
The Infection Control market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infection Control.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Infection Control company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Infection Control in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Infection Control in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Market Overview
1.1 Infection Control Product Introduction
1.2 Global Infection Control Market Size Forecast (2020-2031)
1.3 Infection Control Market Trends & Drivers
1.3.1 Infection Control Industry Trends
1.3.2 Infection Control Market Drivers & Opportunity
1.3.3 Infection Control Market Challenges
1.3.4 Infection Control Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Infection Control Players Revenue Ranking (2024)
2.2 Global Infection Control Revenue by Company (2020-2025)
2.3 Key Companies Infection Control Manufacturing Base Distribution and Headquarters
2.4 Key Companies Infection Control Product Offered
2.5 Key Companies Time to Begin Mass Production of Infection Control
2.6 Infection Control Market Competitive Analysis
2.6.1 Infection Control Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Infection Control Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infection Control as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Disinfection Products
3.1.2 Sterilization Products and Services
3.2 Global Infection Control Sales Value by Type
3.2.1 Global Infection Control Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Infection Control Sales Value, by Type (2020-2031)
3.2.3 Global Infection Control Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals & Clinics
4.1.2 Life Sciences Industry
4.1.3 Medical Device Companies
4.1.4 Pharmaceutical Companies
4.1.5 Food Industry
4.1.6 Other
4.2 Global Infection Control Sales Value by Application
4.2.1 Global Infection Control Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Infection Control Sales Value, by Application (2020-2031)
4.2.3 Global Infection Control Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Infection Control Sales Value by Region
5.1.1 Global Infection Control Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Infection Control Sales Value by Region (2020-2025)
5.1.3 Global Infection Control Sales Value by Region (2026-2031)
5.1.4 Global Infection Control Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Infection Control Sales Value, 2020-2031
5.2.2 North America Infection Control Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Infection Control Sales Value, 2020-2031
5.3.2 Europe Infection Control Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Infection Control Sales Value, 2020-2031
5.4.2 Asia Pacific Infection Control Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Infection Control Sales Value, 2020-2031
5.5.2 South America Infection Control Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Infection Control Sales Value, 2020-2031
5.6.2 Middle East & Africa Infection Control Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Infection Control Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Infection Control Sales Value, 2020-2031
6.3 United States
6.3.1 United States Infection Control Sales Value, 2020-2031
6.3.2 United States Infection Control Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Infection Control Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Infection Control Sales Value, 2020-2031
6.4.2 Europe Infection Control Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Infection Control Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Infection Control Sales Value, 2020-2031
6.5.2 China Infection Control Sales Value by Type (%), 2024 VS 2031
6.5.3 China Infection Control Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Infection Control Sales Value, 2020-2031
6.6.2 Japan Infection Control Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Infection Control Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Infection Control Sales Value, 2020-2031
6.7.2 South Korea Infection Control Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Infection Control Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Infection Control Sales Value, 2020-2031
6.8.2 Southeast Asia Infection Control Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Infection Control Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Infection Control Sales Value, 2020-2031
6.9.2 India Infection Control Sales Value by Type (%), 2024 VS 2031
6.9.3 India Infection Control Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 STERIS
7.1.1 STERIS Profile
7.1.2 STERIS Main Business
7.1.3 STERIS Infection Control Products, Services and Solutions
7.1.4 STERIS Infection Control Revenue (US$ Million) & (2020-2025)
7.1.5 STERIS Recent Developments
7.2 Getinge
7.2.1 Getinge Profile
7.2.2 Getinge Main Business
7.2.3 Getinge Infection Control Products, Services and Solutions
7.2.4 Getinge Infection Control Revenue (US$ Million) & (2020-2025)
7.2.5 Getinge Recent Developments
7.3 Ecolab
7.3.1 Ecolab Profile
7.3.2 Ecolab Main Business
7.3.3 Ecolab Infection Control Products, Services and Solutions
7.3.4 Ecolab Infection Control Revenue (US$ Million) & (2020-2025)
7.3.5 Ecolab Recent Developments
7.4 3M
7.4.1 3M Profile
7.4.2 3M Main Business
7.4.3 3M Infection Control Products, Services and Solutions
7.4.4 3M Infection Control Revenue (US$ Million) & (2020-2025)
7.4.5 3M Recent Developments
7.5 Advanced Sterilization Products
7.5.1 Advanced Sterilization Products Profile
7.5.2 Advanced Sterilization Products Main Business
7.5.3 Advanced Sterilization Products Infection Control Products, Services and Solutions
7.5.4 Advanced Sterilization Products Infection Control Revenue (US$ Million) & (2020-2025)
7.5.5 Advanced Sterilization Products Recent Developments
7.6 Cantel Medical
7.6.1 Cantel Medical Profile
7.6.2 Cantel Medical Main Business
7.6.3 Cantel Medical Infection Control Products, Services and Solutions
7.6.4 Cantel Medical Infection Control Revenue (US$ Million) & (2020-2025)
7.6.5 Cantel Medical Recent Developments
7.7 Sotera Health
7.7.1 Sotera Health Profile
7.7.2 Sotera Health Main Business
7.7.3 Sotera Health Infection Control Products, Services and Solutions
7.7.4 Sotera Health Infection Control Revenue (US$ Million) & (2020-2025)
7.7.5 Sotera Health Recent Developments
7.8 MMM Group
7.8.1 MMM Group Profile
7.8.2 MMM Group Main Business
7.8.3 MMM Group Infection Control Products, Services and Solutions
7.8.4 MMM Group Infection Control Revenue (US$ Million) & (2020-2025)
7.8.5 MMM Group Recent Developments
7.9 Matachana
7.9.1 Matachana Profile
7.9.2 Matachana Main Business
7.9.3 Matachana Infection Control Products, Services and Solutions
7.9.4 Matachana Infection Control Revenue (US$ Million) & (2020-2025)
7.9.5 Matachana Recent Developments
7.10 Belimed AG
7.10.1 Belimed AG Profile
7.10.2 Belimed AG Main Business
7.10.3 Belimed AG Infection Control Products, Services and Solutions
7.10.4 Belimed AG Infection Control Revenue (US$ Million) & (2020-2025)
7.10.5 Belimed AG Recent Developments
7.11 Halyard Health
7.11.1 Halyard Health Profile
7.11.2 Halyard Health Main Business
7.11.3 Halyard Health Infection Control Products, Services and Solutions
7.11.4 Halyard Health Infection Control Revenue (US$ Million) & (2020-2025)
7.11.5 Halyard Health Recent Developments
7.12 Metrex Research
7.12.1 Metrex Research Profile
7.12.2 Metrex Research Main Business
7.12.3 Metrex Research Infection Control Products, Services and Solutions
7.12.4 Metrex Research Infection Control Revenue (US$ Million) & (2020-2025)
7.12.5 Metrex Research Recent Developments
7.13 Reckitt Benckiser
7.13.1 Reckitt Benckiser Profile
7.13.2 Reckitt Benckiser Main Business
7.13.3 Reckitt Benckiser Infection Control Products, Services and Solutions
7.13.4 Reckitt Benckiser Infection Control Revenue (US$ Million) & (2020-2025)
7.13.5 Reckitt Benckiser Recent Developments
7.14 Pal International
7.14.1 Pal International Profile
7.14.2 Pal International Main Business
7.14.3 Pal International Infection Control Products, Services and Solutions
7.14.4 Pal International Infection Control Revenue (US$ Million) & (2020-2025)
7.14.5 Pal International Recent Developments
8 Industry Chain Analysis
8.1 Infection Control Industrial Chain
8.2 Infection Control Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Infection Control Sales Model
8.5.2 Sales Channel
8.5.3 Infection Control Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
List of Figures
Related Reports
The global Infection Control market was valued at US$ 16880 million in 2023 and is anticipated to reach US$ 22490 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 89
USD 2900.00
(Single User License)
The global market for Infection Control was estimated to be worth US$ 16880 million in 2023 and is forecast to a readjusted size of US$ 22490 million by 2030 with a CAGR of 3.7% during the forecast period 2024-2030
Published Date: 2024-01-24
Pages: 108
USD 3950.00
(Single User License)
Market Analysis and Insights: Global Infection Control Market
Published Date: 2024-04-12
Pages: 107
USD 4900.00
(Single User License)
The global market for Infection Control was valued at US$ 18690 million in the year 2024 and is projected to reach a revised size of US$ 24020 million by 2031, growing at a CAGR of 3.7% during the forecast period.
Published Date: 2025-02-27
Pages: 84
USD 2900.00
(Single User License)
The global Infection Control market size was US$ 18690 million in 2024 and is forecast to a readjusted size of US$ 24020 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 96
USD 4250.00
(Single User License)
The global Infection Control market was valued at US$ 19310 million in 2025 and is anticipated to reach US$ 24820 million by 2032, at a CAGR of 3.7% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 114
USD 2900.00
(Single User License)
The global market for Infection Control was estimated to be worth US$ 19310 million in 2025 and is projected to reach US$ 24820 million, growing at a CAGR of 3.7% from 2026 to 2032.
Published Date: 2026-07-15
Pages: 119
USD 3950.00
(Single User License)
The global Infection Control market was valued at US$ 16880 million in 2023 and is anticipated to reach US$ 22490 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 89
The global market for Infection Control was estimated to be worth US$ 16880 million in 2023 and is forecast to a readjusted size of US$ 22490 million by 2030 with a CAGR of 3.7% during the forecast period 2024-2030
Published: 2024-01-24
Pages: 108
Market Analysis and Insights: Global Infection Control Market
Published: 2024-04-12
Pages: 107
The global market for Infection Control was valued at US$ 18690 million in the year 2024 and is projected to reach a revised size of US$ 24020 million by 2031, growing at a CAGR of 3.7% during the forecast period.
Published: 2025-02-27
Pages: 84
The global Infection Control market size was US$ 18690 million in 2024 and is forecast to a readjusted size of US$ 24020 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 96
The global Infection Control market was valued at US$ 19310 million in 2025 and is anticipated to reach US$ 24820 million by 2032, at a CAGR of 3.7% from 2026 to 2032.
Published: 2026-04-27
Pages: 114
The global market for Infection Control was estimated to be worth US$ 19310 million in 2025 and is projected to reach US$ 24820 million, growing at a CAGR of 3.7% from 2026 to 2032.
Published: 2026-07-15
Pages: 119
REPORT COVERAGE
Market Segmentation
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research